多时相CTA联合脑CTP对缺血性脑卒中患者诊断的价值研究.pdf

28 脑与神经疾病杂志2021年第29卷第1期
[9] Davis SM, Broderick J. Henneric i M. et al; Recomliinant Activated emergent invasive procedures[J].Ann Hematol,2015,94:1457-1461.
factor VII intracerebral hemorrhage trial investigators:Hematoma [13] 高云娟，张海浪•
growth is a determinant of mortality and poor outcome after 反应分析[J].中国医院药学杂志,2017,37(11):1085-1088,1096.
intracerebral hemorrhage| J].N• • urology, 2006, 66(8):1175-11X1. [14] Desborough MJ, Oakl and KA. Landoni G, et al. Desmopressin for
[10] Barletta akDesniopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: A
antiplatelet reversal in neurocritieal carefj].(^rit Care Med, 2016, systematic review and meta-analysis of randomized controlled
44(12 Suppl 1):26& trials[J].J Thromh Haemost,2017,15 ( 2 ) :263-272.
[11] 杨一萍，谢丽丽，宁小金，等•颅内出血患者抗栓药逆转指南美 [15] Crescenzi G, Landoni G, Biondi-Zoccai G, et al. Desmopressin
国神经重症监护学会和美国重症医学会对医疗卫生专业人员的 reduces transfusion needs after surgery: A meta-analysis of
声明[J].国际脑血管病杂志,2016,24(11):9